Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice de réir Marijn A. Gillissen, Greta de Jong, Martijn Kedde, Etsuko Yasuda, Sophie E. Levie, Gemma Moiset, Paul J. Hensbergen, Arjen Q. Bakker, Koen Wagner, Jullien Villaudy, Pauline M. van Helden, Hergen Spits, Mette D. Hazenberg

Faigh an téacs iomlán

Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager de réir Lisa A. King, Myrthe Veth, Victoria Iglesias-Guimarais, Iris Blijdorp, Jan Kloosterman, André N. Vis, Rob C. Roovers, David Lutje Hulsik, Thilo Riedl, Anton E.P. Adang, Paul W.H.I. Parren, Pauline M. van Helden, Tanja D. de Gruijl, Hans J. van der Vliet

Faigh an téacs iomlán

Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity de réir Dennis Hoving, Alexandre H. C. Marques, Wesley Huisman, Beckley A. Nosoh, Alicia C. de Kroon, Oscar R. J. van Hengel, Bing-Ru Wu, Rosanne A. M. Steenbergen, Pauline M. van Helden, Britta C. Urban, Nisha Dhar, Daniela M. Ferreira, Gaurav Kwatra, Cornelis H. Hokke, Simon P. Jochems

Faigh an téacs iomlán

Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion de réir Lisa A. King, Lisa A. King, Lisa A. King, Milon de Jong, Milon de Jong, Milon de Jong, Myrthe Veth, Myrthe Veth, Myrthe Veth, David Lutje Hulsik, Parsa Yousefi, Victoria Iglesias-Guimarais, Pauline M. van Helden, Tanja D. de Gruijl, Tanja D. de Gruijl, Tanja D. de Gruijl, Hans J. van der Vliet, Hans J. van der Vliet, Hans J. van der Vliet

Faigh an téacs iomlán